{
    "id": "correct_award_00039_2",
    "rank": 29,
    "data": {
        "url": "https://www.carnegie.org/awards/honoree/andrew-schally/",
        "read_more_link": "",
        "language": "en",
        "title": "Carnegie Corporation of New York",
        "top_image": "https://media.carnegie.org/filer_public_thumbnails/filer_public/34/37/3437acdd-5f60-44ea-86f1-22fc59ea1b2c/dr_andrew_v_schally-portrait.jpeg__1200x630_q85_subsampling-2.jpg",
        "meta_img": "https://media.carnegie.org/filer_public_thumbnails/filer_public/34/37/3437acdd-5f60-44ea-86f1-22fc59ea1b2c/dr_andrew_v_schally-portrait.jpeg__1200x630_q85_subsampling-2.jpg",
        "images": [
            "https://www.carnegie.org/static/images/logo-blue.svg",
            "https://www.carnegie.org/static/images/great-immigrants.png",
            "https://www.carnegie.org/static/images/liberty-torch.png",
            "https://media.carnegie.org/filer_public_thumbnails/filer_public/34/37/3437acdd-5f60-44ea-86f1-22fc59ea1b2c/dr_andrew_v_schally-portrait.jpeg__288x288_q85_crop_subsampling-2_upscale.jpg",
            "https://media.carnegie.org/filer_public_thumbnails/filer_public/e0/a2/e0a20acb-137d-4172-8b3d-ce5899d7e341/anthony_hopkins.jpeg__267x267_q85_crop_subsampling-2_upscale.jpg",
            "https://media.carnegie.org/filer_public_thumbnails/filer_public/5b/af/5bafc24d-73d5-469e-a299-ed25f00f3d3c/angel_cabrera-2.jpeg__267x267_q85_crop_subsampling-2_upscale.jpg",
            "https://media.carnegie.org/filer_public_thumbnails/filer_public/5f/3d/5f3d67cd-3b23-4344-98ee-a58f345aeeb2/ayman_mohyeldin.jpeg__267x267_q85_crop_subsampling-2_upscale.jpg",
            "https://media.carnegie.org/filer_public_thumbnails/filer_public/1b/81/1b818476-d2e4-41b5-96f0-38ace6587ea3/chinelo_okparanta.jpeg__267x267_q85_crop_subsampling-2_upscale.jpg",
            "https://www.carnegie.org/static/images/icons/footer-x.svg",
            "https://www.carnegie.org/static/images/icons/footer-facebook.svg",
            "https://www.carnegie.org/static/images/icons/footer-instagram.svg",
            "https://www.carnegie.org/static/images/icons/footer-linkedin.svg",
            "https://www.carnegie.org/static/images/icons/footer-youtube.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "None",
        "meta_lang": "en",
        "meta_favicon": "/apple-touch-icon-57x57.png",
        "meta_site_name": "Carnegie Corporation of New York",
        "canonical_link": "https://www.carnegie.org/awards/honoree/andrew-schally/",
        "text": "Dr. Andrew V. Schally, a Nobel Laureate in Medicine, is continuing his work on the development and preclinical evaluation of peptide analogs with antitumor activity. This program is aimed at providing a theoretical, preclinical, and mechanistic basis for planned clinical trials with these peptide analogs in various cancers, including prostatic, pancreatic, gastric, colorectal, malignant brain tumors, small cell lung cancer and non-small cell lung cancer, bladder cancer, renal and thyroid cancer, osteosarcomas, melanomas, hepatocellular carcinoma, and lymphomas. Overall, this program has the potential to make a significant impact on the improvements of therapeutic methods and the delivery of care to the patients afflicted with various cancers. Updated July 2017"
    }
}